Has a wide expertise in the manufacture of both APIs and intermediates of interest in the pharmaceutical industry resulting from an experience of more than 30 years of innovation and cGMP manufacturing.
Our continuous aim for the highest quality standards has resulted in the company being approved by the FDA, European and Japanese Agencies (our main markets) for several sterile and non-sterile products. The company was also recognized in 2006 as a pharmaceutical laboratory (NR 6273E).
Has a wide experience in the synthesis of APIs belonging to several pharmaceutical categories: antibiotics, penicillin derivatives, cardiocirculatory, antineoplastics, antiarthritics, etc under cGMP regulations.
We traditionally export to markets such as USA, Japan, European Union, South America, Turkey, India.